Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025658539> ?p ?o ?g. }
- W3025658539 abstract "Background: The purpose of this study was to investigate if admission levels of total tau (T-tau) and β-amyloid isoforms 1-40 (Aβ40) and 1-42 (Aβ42) could predict clinical outcome in patients with mild traumatic brain injury (mTBI). Methods: A total of 105 patients with mTBI [Glasgow Coma Scale (GCS)≥13] recruited in Turku University Hospital, Turku, Finland were included in this study. Blood samples were drawn within 24 hours of admission for analysis of plasma T-tau, Aβ40 and Aβ42. Patients were divided into computed tomography (CT)-positive and CT-negative groups. The outcome was assessed 6-12 months after the injury using the Extended Glasgow Outcome Scale (GOSE). Outcomes were defined as complete (GOSE=8) or incomplete (GOSE<8) recovery. The Rivermead Post Concussion Symptoms Questionnaire (RPCSQ) was also used to assess mTBI-related symptoms. Predictive values of the biomarkers were analyzed independently, in panels and together with clinical parameters. Results: The admission levels of plasma T-tau, Aβ40 and Aβ42 were not significantly different between patients with complete and incomplete recovery. The levels of T-tau, Aβ40 and Aβ42 could poorly predict complete recovery, with areas under the receiver operating characteristic curve 0.56, 0.52 and 0.54, respectively. For the whole cohort, there was a significant negative correlation between the levels of T-tau and ordinal GOSE score (Spearman ρ=-0.231, p=0.018). In a multivariate logistic regression model including age, GCS, duration of posttraumatic amnesia, Injury severity score (ISS), time from injury to sampling, and CT findings, none of the biomarkers could predict complete recovery independently or together with the other two biomarkers. Plasma levels of T-tau, Aβ40 and Aβ42 did not significantly differ between the outcome groups either within the CT-positive or CT-negative subgroups. Levels of Aβ40 and Aβ42 did not significantly correlate with outcome, but in the CT-positive subgroup, the levels of T-tau significantly correlated with ordinal GOSE score (Spearman ρ=-0.288, p=0.035). The levels of T-tau, Aβ40 and Aβ42 were not correlated with the RPCSQ scores. Conclusion: The early levels of T-tau are correlated with the outcome in patients with mTBI, but none of the biomarkers either alone or in any combinations could predict complete recovery in patients with mTBI." @default.
- W3025658539 created "2020-05-21" @default.
- W3025658539 creator A5004714555 @default.
- W3025658539 creator A5006309076 @default.
- W3025658539 creator A5008709010 @default.
- W3025658539 creator A5019836672 @default.
- W3025658539 creator A5020185605 @default.
- W3025658539 creator A5020219114 @default.
- W3025658539 creator A5025313057 @default.
- W3025658539 creator A5026652859 @default.
- W3025658539 creator A5030099015 @default.
- W3025658539 creator A5037799919 @default.
- W3025658539 creator A5057778218 @default.
- W3025658539 creator A5059462038 @default.
- W3025658539 creator A5063237156 @default.
- W3025658539 creator A5063507283 @default.
- W3025658539 creator A5064938667 @default.
- W3025658539 creator A5066932645 @default.
- W3025658539 creator A5072685466 @default.
- W3025658539 creator A5077552925 @default.
- W3025658539 creator A5079766290 @default.
- W3025658539 creator A5089223544 @default.
- W3025658539 date "2020-05-13" @default.
- W3025658539 modified "2023-10-18" @default.
- W3025658539 title "Admission Levels of Total Tau and β-Amyloid Isoforms 1–40 and 1–42 in Predicting the Outcome of Mild Traumatic Brain Injury" @default.
- W3025658539 cites W1480729244 @default.
- W3025658539 cites W1605885548 @default.
- W3025658539 cites W1742108937 @default.
- W3025658539 cites W1816716886 @default.
- W3025658539 cites W1964977367 @default.
- W3025658539 cites W1968007289 @default.
- W3025658539 cites W1972491904 @default.
- W3025658539 cites W1979997422 @default.
- W3025658539 cites W1981337226 @default.
- W3025658539 cites W1981987082 @default.
- W3025658539 cites W1991893128 @default.
- W3025658539 cites W1994030229 @default.
- W3025658539 cites W1999684482 @default.
- W3025658539 cites W2011595299 @default.
- W3025658539 cites W2042028457 @default.
- W3025658539 cites W2054931962 @default.
- W3025658539 cites W2056208640 @default.
- W3025658539 cites W2057383858 @default.
- W3025658539 cites W2062993238 @default.
- W3025658539 cites W2064335645 @default.
- W3025658539 cites W2079553954 @default.
- W3025658539 cites W2080601011 @default.
- W3025658539 cites W2102960897 @default.
- W3025658539 cites W2103982815 @default.
- W3025658539 cites W2123546024 @default.
- W3025658539 cites W2154813265 @default.
- W3025658539 cites W2155038264 @default.
- W3025658539 cites W2160591264 @default.
- W3025658539 cites W2170921124 @default.
- W3025658539 cites W2217184110 @default.
- W3025658539 cites W2272368057 @default.
- W3025658539 cites W2286535726 @default.
- W3025658539 cites W2287370799 @default.
- W3025658539 cites W2327228538 @default.
- W3025658539 cites W2332799190 @default.
- W3025658539 cites W2342233016 @default.
- W3025658539 cites W2466729373 @default.
- W3025658539 cites W2522754681 @default.
- W3025658539 cites W2534426154 @default.
- W3025658539 cites W2592551987 @default.
- W3025658539 cites W2606398663 @default.
- W3025658539 cites W2738010656 @default.
- W3025658539 cites W2767813783 @default.
- W3025658539 cites W2789827414 @default.
- W3025658539 cites W2899914781 @default.
- W3025658539 cites W2914243041 @default.
- W3025658539 cites W2919350187 @default.
- W3025658539 cites W2940677715 @default.
- W3025658539 cites W2944160948 @default.
- W3025658539 cites W2951707943 @default.
- W3025658539 cites W2972355048 @default.
- W3025658539 cites W2993902261 @default.
- W3025658539 cites W4251671944 @default.
- W3025658539 cites W4293108385 @default.
- W3025658539 cites W573909598 @default.
- W3025658539 doi "https://doi.org/10.3389/fneur.2020.00325" @default.
- W3025658539 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7237639" @default.
- W3025658539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32477238" @default.
- W3025658539 hasPublicationYear "2020" @default.
- W3025658539 type Work @default.
- W3025658539 sameAs 3025658539 @default.
- W3025658539 citedByCount "9" @default.
- W3025658539 countsByYear W30256585392021 @default.
- W3025658539 countsByYear W30256585392022 @default.
- W3025658539 countsByYear W30256585392023 @default.
- W3025658539 crossrefType "journal-article" @default.
- W3025658539 hasAuthorship W3025658539A5004714555 @default.
- W3025658539 hasAuthorship W3025658539A5006309076 @default.
- W3025658539 hasAuthorship W3025658539A5008709010 @default.
- W3025658539 hasAuthorship W3025658539A5019836672 @default.
- W3025658539 hasAuthorship W3025658539A5020185605 @default.
- W3025658539 hasAuthorship W3025658539A5020219114 @default.
- W3025658539 hasAuthorship W3025658539A5025313057 @default.
- W3025658539 hasAuthorship W3025658539A5026652859 @default.
- W3025658539 hasAuthorship W3025658539A5030099015 @default.